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Based on a case of a patient with angiosarcoma
(AS) of the right atrium with superior vena cava
syndrome associated with urticaria and
polyarthralgias, who died soon after surgery,
the authors present a brief review of the
subject of cardiac AS, an extremely rare
pathology, usually diagnosed late due to its
non-specific symptomatology. Several topics
are discussed, including mechanisms of
clinical manifestations caused by blood flow
obstruction and valve dysfunction, local
invasion with arrhythmias and pericardial
effusion, embolic phenomena and
constitutional symptoms. Imaging and
histopathologic methods of diagnosis are
considered, as well as references to cytogenetic
analysis. Surgery is the first treatment choice,
but heart AS are frequently not completely
resectable and concomitant metastases at the
time of surgery are common, both usually
leading to a dismal prognosis. Chemotherapy,
radiotherapy and even heart transplantation do
not substantially improve the survival of these
patients. Urticaria is not generally assumed by
most authors to be associated with malignancy,
but there are rare reports of its association with
some malignant tumors. 
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RESUMO
Angiosarcoma Cardíaco - uma Revisão
Baseados no caso dum doente com
angiosarcoma da aurícula direita manifestando
quadro de síndrome da veia cava superior
associado a urticária e poliartralgias, com óbito
poucos dias após cirurgia paliativa, os autores
fazem revisão concisa dos angiosarcomas
cardíacos, tumores extremamente raros e
geralmente diagnosticados tardiamente em
virtude da não especificidade da
sintomatologia. São discutidos os mecanismos
de expressão clínica, resultantes de obstrução
ao fluxo sanguíneo, de disfunção valvular, de
invasão local condicionando arritmias e
derrame pericárdico, fenómenos embólicos e
sintomas constitucionais. O diagnóstico é
considerado em termos de imagiologia,
histopatologia, imunocitoquímica e análise
citogenética. O tratamento de primeira linha é
cirúrgico, mas geralmente os tumores não são
totalmente ressecáveis, para além da frequente
presença de metastização concomitante, ambos
os factores condicionando prognóstico
geralmente muito desfavorável. A
quimioterapia e a radioterapia não oferecem
geralmente grande benefício e, mesmo a
transplantação cardíaca não tem obtido
resultados favoráveis. A maioria dos autores
não encontra dados convincentes da possível
associação entre urticária e tumores malignos,
mas existem algumas referências de casos
clínicos de doentes em que as duas situações
ocorreram concomitantemente. 
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INTRODUCTION
Primary tumors of the heart occur with an
incidence of approximately 0.02% in autopsy
series, being far less common than metastatic
tumors of the heart, which occur 20-40 times
more frequently (1). About 25% of primary heart
tumors are malignant and most of these are
sarcomas (2). 
Cardiac sarcomas are often asymptomatic
until the advanced stages and, even then, cause a
variety of non-specific symptoms and may mimic
other pathologies, delaying diagnosis. The dismal
prognosis results from extensive local invasion
and/or distant metastization at presentation (3). A
high index of suspicion remains the key for early
diagnosis of a malignant cardiac tumor.
According to Shanmugan (4), cardiac sarcomas
manifest via several mechanisms: (1) obstruction
to blood flow and interference with valve
function; (2) local invasion causing arrhythmias
or pericardial effusion with tamponade; (3)
embolic phenomena from tumor fragments or
peritumoral thrombi; (4) systemic or constitu-
tional symptoms including dyspnea, syncope,
chest pain, fever, malaise and weight loss. Left
chamber tumors can cause cerebral, coronary,
and retinal emboli. Right-sided tumors may be
the source of pulmonary emboli that can cause
pulmonary hypertension when extensive.
Advances in noninvasive cardiovascular
imaging techniques - especially transesophageal
echocardiography (TEE) (5), computed tomography
(CT) and magnetic resonance imaging (MRI) (6) -
have greatly facilitated diagnostic evaluation,
enabling rapid identification of intracardiac
masses.
Histopathologic classification of cardiac
sarcomas is generally obtained by combining
both morphologic features and immunohisto-
chemical staining (7, 8), which can identify several
tumor types: angiosarcoma, undifferentiated
sarcoma, osteosarcoma, fibrosarcoma, malignant
fibrous histiocytoma, leiomyosarcoma, myxosar-
coma, synovial sarcoma, neurofibrosarcoma and
rhabdomyosarcoma. AS is the most common type
in almost all series (3, 9, 10, 11). Cardiac AS seem to
arise in a younger population (42-43 years) than
in other soft tissue locations (60 years). They
are generally large, grossly hemorrhagic,
multilobular right atrial masses that spread along
the epicardial surface and replace the right atrial
wall, and may protrude into or fill the adjacent
cardiac chamber(s).
Urticaria is due to local increase in
permeability of capillaries and venules. These
changes are dependent on activation of cutaneous
mast cells and basophils, which contain a range
of mediators, predominantly histamine (12).
Urticaria is one of the least common markers of
internal disease, and two of the major textbooks
in dermatology do not consider its association
with malignant diseases proved (12,13). However,
there are occasional reports of chronic urticaria
occurring in association with malignant neoplasia
in Braverman's textbook (14). The authors describe
a case of a patient with heart AS located in the
right atrium, who was previously admitted twice
to our hospital due to unexplained recurrent
urticaria and polyarthralgias, and whose
diagnosis of heart AS was only made during his
third admission, with a clinical picture of
superior vena cava syndrome associated with
recurrence of urticaria and polyarthralgias. To our
knowledge this association has not previously
been described.
CASE REPORT
On May 9 2006, a 47-year-old white man was
transferred from the Dermatology Unit of our
hospital to our Internal Medicine Unit due to a
clinical diagnosis of acute superior vena cava
syndrome. He had previously been admitted to
the Dermatology Unit from August 29 to
September 8 2005 for 15 days with foot edema
and prurigo, with pruriginous erythematous
papulomatous exanthema, appearing first on the
legs, but quickly extending to all skin surfaces,
including the face and palmar and plantar
surfaces. Five days before that admission the
evolution was complicated by fever (38-39 ºC),
prostration and malaise, odinalgia and symmetric
arthralgias of several joints: ankle, tarsal, knees,
wrists, hip, proximal interphalangeal joints of the
hands, and shoulder. The patient reported a
Billroth type II duodenal ulcer operation 18 years
before and chronic atrial fibrillation for several
years, and had been treated for 3 months with
nonsteroidal anti-inflammatory and analgesic
drugs for frequent back pain caused by chronic
osteoarthropathy of the lumbar spine. He denied
taking any other drugs. No personal or family578
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history of atopic allergic diseases was obtained.
He was a heavy smoker but reported no alcohol
consumption. On physical examination the
patient was febrile (38 ºC), with blood pressure of
89/60 mmHg and complete arrhythmia with an
irregular pulse of approximately 74 bpm. The
oropharynx was normal, a slight hepatomegaly
was detected, and there were widespread
erythematous cutaneous plaques and macular
exanthema, confluent in certain areas (shoulders
and knees). There was some limitation to
movement due to joint pains although without
joint swelling, but no other abnormal physical
signs were detected. Blood tests showed no
anemia, ESR 80 mm (1st hour), leukocytosis
14.5x109/L (N 4.0-10.0) with 83% neutrophils,
platelets 499x109/L (150-400), GOT 101 U/L
(17-59), GPT 93 U/L (21-72), gamma-GT 272
U/L (15-73), normal values of glycemia, serum
urea, creatinine, and alkaline phosphatase,
normal INR and APTT, negative serology for viral
hepatitis A, B, C, CMV, herpes, EBV, HIV,
syphilis, and Borrelia, slightly elevated IgA 570
mg/dL (88-440) and IgE 347 UI/L (N <100).
Bacteriologic cultural examination of ocular
exudate was positive for colonies of methicillin-
sensitive Staphylococcus aureus. A complete
immunologic study for the diagnosis of
autoimmune diseases was performed, including
collagen/vasculitic diseases and autoimmune
thyroiditis, which was completely negative. C1
inhibitor protein and C1 inhibitor function were
normal. Although most of the skin lesions
disappeared within 24 hours with hydroxyzine
therapy, with a behavior resembling urticaria, a
skin biopsy in one of the areas with confluent
lesions to exclude a diagnosis of Sweet
syndrome showed a slight perivascular diffuse
mixed inflammatory infiltrate of neutrophils,
lymphocytes and histiocytes of the reticular
dermis, findings that were in favor of a diagnosis
of urticaria. No vasculitis was found. The patient
was advised to stop taking the drugs used before
admission. After discharge the patient was
admitted again 15 days later to the Internal
Medicine Unit for one week, with the same
symptoms and also rapidly improving with
the same therapy. Investigation was also negative
for a different diagnosis at that time. The
patient was subsequently followed in the
outpatient Dermatology Unit, due to intermittent
episodes of unexplained recurrent urticaria and
polyarthralgias. He stated that he had not
continued with the previous therapy, except on
one occasion. He was admitted again to the
Dermatology Unit on April 16 2006 because of
rapidly developing and progressive rest and effort
dyspnea, face, neck and upper thorax edema, and
external jugular vein dilatation. No abnormal
venous circulation was detected. Blood pressure
was 160/40 mm Hg, there was atrial fibrillation
with ventricular rate of approximately 100 bpm
and superficial respiratory rate of 24 bpm.
Pleural effusion, clinically suspected, was
confirmed on thorax X-ray, which also showed
cardiomegaly. Abdominal examination revealed
slightly painful hepatomegaly with hepatojugular
reflux and abdominal wall edema. A moderate
degree of dependent edema was also seen on the
legs. No lymphadenopathies were detected. He
had come to the Emergency Unit several days
before with the same symptoms, for which he had
been treated with corticosteroids, but without
amelioration. Blood tests revealed slight
normocytic normochromic anemia (hemoglobin
12.2 g/dL), leukocytes 18,600 (62% N), ESR 18
mm, platelets 98x109/L falling in two days to
59x109/L, INR 1.65, APTT 28.9 s, normal values
of chromogenic protein C, protein S, antithrombin
III, factor VII, VIII, IX, and X; factor V 47% (N
50.0-150.0), negative test for activated protein C
resistance; normal values of glycemia, serum
urea and creatinine, uric acid, proteinogram,
cholesterol, triglycerides, calcium, phosphate,
magnesium, and alkaline phosphatase; GOT 86
U/L, GPT 99 U/L, gamma-GT 257 U/L, DHL
1094 U/L (313-618). Thyroid function tests were
normal and antithyroid antibody tests negative.
Arterial blood gases: PaO2 65.6 mmHg (83.0-
108.0), PaCO2 34.6 mmHg (32.0-48.0), O2 sat
93.3%, pH 7.442, base excess -0.3, HCO3- 24.5
mmHg, lactic acid 1.9 mmol/L (N 0.6-1.6).
Several serum tumor markers were normal (CEA,
α-FP, CA 19.9, PSA) except CA 125 = 278.0
U/mL (N <35.0) No clinical, laboratory or
radiological signs in favor of infection were found.
Due to technical difficulties and to the patient's
hemodynamic and respiratory instability, two-
dimensional transthoracic echocardiography
(TTE) was not conclusive and showed no
abnormalities. Cytopathologic examination of
serohematic pleural fluid was negative for
neoplastic cells and for mycobacterial culture.
Abdominal ultrasonography and CT scan of the 579
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thorax without contrast revealed no sign of
neoplastic lesions. A pleural catheter was
inserted to permit symptomatic respiratory relief.
Meanwhile an urgent helical angio CT of the
thorax showed a voluminous tumor mass
measuring 7x4 cm with heterogeneous contrast
enhancement, involving the affluence of the
superior vena cava in the right atrium, extending
to the atrial septum and also to the initial part of
the ascending aorta (Figs. 1 a, b, c). The lumen of
the superior vena cava was compressed, although
permeable. There was no compromise of the
jugular veins or of the initial part of either
innominate vein. Apart from the right pleural
effusion there were no other abnormalities. TEE
confirmed the existence of a heterogeneous
echogenic mass partially occupying the right
atrial cavity and adjacent to the superior vena
cava orifice (Figs. 1 d, e, f). The superior vena
cava was dilated but no other abnormalities were
detected. Urgent thoracic surgery was decided on
May 12 2006 to obtain a correct diagnosis and to
permit palliative symptomatic treatment.
Pronounced adhesive constrictive pericarditis
was found that made dissection between the
epicardium and pericardium almost impossible.
The right atrium was hard and distended and its
external surface was infiltrated. The right atrial
cavity of the was partially occupied by a rough
tumor merging with its free wall, obstructing the
superior vena cava, and extending to the atrial
septum. The entry to the superior vena cava was
free and with partial removal of the tumor, it was
unobstructed. In the postoperative period,
multiorgan failure developed rapidly, with death
on the fourth day. On necropsy we found global
cardiomegaly, with involvement of the entire
heart by a hemorrhagic infiltrative tumor
extending to the first part of the great vessels of
the heart. Microscopically the tumor diffusely
infiltrated the myocardial tissue (Figs. 2 a, b) and
showed several anastomosing vascular channels
lined by atypical endothelial cells (Fig. 2 c).
Immunohistochemical stain for CD34 was
positive in the endothelial cells (Fig. 2 d).
Atypical endothelial cells were also seen
infiltrating the pericardium (Fig. 2 e). No lung
metastases were found, but one hemorrhagic
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Figure 1 a, b, c: Thoracic angio-CT: three consecutive thoracic CT images after intravenous contrast, showing extensive solid
lesion (open arrow), with heterogeneous contrast enhancement, diffusely infiltrating the right atrial wall, reducing its lumen.
The lesion is compressing the superior vena cava (closed arrow), although the latter remains permeable, and involves the
ascending aorta. All CT characteristics suggested malignant disease. There was moderate right pleural effusion with inserted
pleural catheter and passive collapse of the inferior lobe, with slight left pleural and pericardial effusion. 
Figure 1 d, e, f: TEE: d) TEE (0 degrees): tumor (T) in right atrium; e) TEE (113 degrees): tumor (T) in right atrium next to
aortic root (AO); f) TEE (84 degrees): heteroechogenic tumor (T) in right atrium (RA) extending to superior vena cava (SVC).
LA: left atrium.
nodule was also found on lymph node, left
suprarenal gland and liver. Microscopically all
these nodules were metastases of the
angiosarcoma of the right atrium (Figs. 2 f, g, h).
DISCUSSION
Clinical presentation of primary malignant
cardiac neoplasms is determined by many
factors, including tumor location, size, growth
rate, tendency for embolization (friability), and
degree of invasiveness. Intracavitary tumors tend
to obstruct cardiac valves or major vessels or to
produce emboli. Myocardial lesions may affect
the conduction system of the heart resulting
in arrhythmias. Pericardial lesions lead to
pericardial tamponade (15). 
Heart AS mostly arise in the right atrium and
have a tendency to occur in the third to fifth
decade and more commonly in males (16). They
frequently extend to the pericardium, vena cava,
or tricuspid valve, causing tamponade and/or
heart inflow obstruction with superior vena cava
syndrome. The exact primary site of an extensive
pericardial tumor in continuity with the right
atrial or ventricular component may be unclear,
but most originate in the right atrial chamber (17).
Metastases in the lungs are common and often
widespread at diagnosis, in 66 to 89% of patients
(8, 18). Other sites of metastization are lymph nodes,
bone, liver, brain, bowel, spleen, adrenal glands,
pleura, diaphragm, kidneys, thyroid, and skin(19).
Besides the symptoms described, heart AS may
present with hemoptysis secondary to diffuse
pulmonary hemorrhage (20) and other clinical
features related to the sites of metastases.
Sometimes pulmonary artery or right ventricular
outflow obstruction can cause cardiac arrest (4).
Most patients die within a few months after
symptom onset (17), despite surgical resection and
even in cases treated by heart transplantation (21).
Chest X-ray is of little help for the detection of
cardiac AS, as it only reveals changes secondary
to hemodynamic consequences of the tumor
growth: cardiomegaly, heart failure, pleural
effusion, focal cardiac mass, pulmonary
consolidation, or pericardial effusion.
Echocardiography is a reliable, noninvasive,
and widely available tool for detecting cardiac
tumors, the site of tumor attachment, the pattern
of tumor movement and tumor size. Due to
technical reasons TTE may have limited
diagnostic accuracy (22, 23). Moreover, TEE has
a much higher resolution for differentiating
between benign and malignant tumors, which
typically disrupt, infiltrate, and obscure the tissue
planes of adjacent cardiac anatomy (24). The
presence of a tumor in the pulmonary veins or
extension into the vena cava has been described
as an useful aid in the differentiation of a
malignant neoplasm from myxoma (5, 24).
Despite these advantageous qualities of TEE,
its performance in soft tissue characterization is
not as good as that achieved with helical CT and
MRI, and myocardial disease such as tumor
infiltration is not clearly depicted. Most
importantly, both TTE and TEE provide limited
views of the mediastinum and cannot be used to
evaluate extracardiac manifestations of the
disease. However, both CT and MRI are not as 581
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Figure 2 a, b, c, d, e, f, g, h: Histopathology: a) right atrial
AS; b) AS of the right atrium infiltrating myocardial cells; c)
AS: cellular area with atypical endothelial cells; d) AS:
immunohistochemical stain for CD34 revealing positive
endothelial cells; e) AS: atypical endothelial cells infiltrating
the pericardium; f) AS: mediastinal lymph node metastasis;
g) AS: atypical papillary fronds lined by hyperchromatic
endothelial cells. Adrenal metastasis; h) AS: liver
metastasis.
useful in the characterization of moving
structures such as the cardiac valves (6).   
According to Janigan (17), there are two main
morphological types of cardiac AS, characterized
by: (1) a well-defined mass protruding into a
cardiac chamber, often sparing the atrial septum.
Macroscopically the tumors are hemorrhagic,
necrotic and often adherent to the pericardium.
CT often shows a low-attenuation right atrial
mass, irregular or nodular, usually arising from
the right atrial free wall. Tumor infiltration of the
myocardium, compression of the cardiac
chambers, direct extension into the pericardium,
and involvement of the mediastinal great vessels
are generally well demonstrated in CT and MRI;
(2) a diffusely infiltrative mass extending along
the pericardium. The pericardial space may be
obliterated with hemorrhagic and/or necrotic
tumor debris, which may appear on CT as
pericardial effusion or thickening.
Because of the propensity of heart AS for
hemorrhage and necrosis, it typically has
heterogeneous signal intensity on MRI. Areas
of increased signal intensity on T1-weighted
images may be focal or peripheral and are
thought to represent blood products (6). Local
nodular areas of increased signal intensity
interspersed within areas of intermediate signal
intensity on T1 and T2-weighted images have a
cauliflower-like appearance (25). Linear contrast
material enhancement along vascular lakes gives
a “sunray” appearance to cases with diffuse
pericardial infiltration (26).
AS are considered malignant neoplasms of
endothelial differentiation. They vary from well-
differentiated tumors that are composed of
anastomosing vascular channels lined by
elongated, mononucleated and fusiform
malignant cells occasionally protruding into the
vascular lumen, to undifferentiated tumors
arranged as solid sheets of anaplastic and
spindle-shaped tumor cells. Immunohisto-
chemical stains for CD31, CD34 and factor VIII-
related protein are useful markers to confirm the
endothelial origin of these tumors (20). 
Zu et al. (27) recently reported 55,XY,+der
(1:A)(q10:q10),+2,+7,+8,+19,+20,+21,+22
chromosomal abnormalities in cytogenetic
analysis. Multicolor fluorescent in situ
hybridization on paraffin-embedded tissue
sections illustrated polysomy of chromosome 8.
Immunohistochemical analysis showed high
expression of mutated p53 gene products in
tumor cell nuclei (28, 29).
Surgery is the first-line treatment for cardiac
AS. However, most patients present with
marginally resectable or technically unresectable
disease at diagnosis, generally resulting in poor
survival rates (30). Given the likely inadequacy of
surgical margins and the mortality risk of distant
metastases, both adjuvant radiotherapy and
systemic chemotherapy have been tried, but
unfortunately the results of these multimodality
therapies are disappointing (3, 10). For Lombard-
Cussac et al. (3) heart AS had the worst prognosis
of all cardiac sarcomas, in a series including
adjuvant chemotherapy with doxorubicin. The
usual presence of metastases at the time of
diagnosis only aggravates the problem.
Orthotopic heart transplantation has been
proposed, but the results also are generally not
good (21, 32). Survival after multimodality therapy is
generally short, and only slightly better if the
tumor is completely resectable in selected
patients (33).
Urticaria is due to degranulation of mast and
basophil cells with release of histamine and
other mediators, and is caused by various
etiopathogenic mechanisms. The causes of
urticaria can be divided into four categories (34):
(1) IgE-mediated (allergic), (2) complement-
mediated (immunologic), (3) direct degranu-
lating effect of drugs, neurohormones, opioid
peptides, or other chemicals, (4) direct or indirect
effects of physical stimuli.
Chronic urticaria (CU) is defined as any
pattern of urticariform lesions that occurs at least
twice a week during a period of more than six
weeks (35). Urticaria is generally not considered a
manifestation of neoplasm (36, 37), but it has
occasionally been described together with
choriocarcinoma and rectal cancer (38). In both
instances, successful removal of the tumor
prompted disappearance of the urticaria. To
accept a causal relationship between neoplasm
and concomitant CU it would be necessary to see
complete or partial amelioration of the urticaria
with medical or successful treatment of the
neoplasm. CU may be a manifestation of
hematologic malignancies. In a review by
Karakelides et al. (39) of 1639 patients
presenting with CU between 1994 and 2001, 47
had monoclonal gammopathy of unknown
significance (MGUS), 142 had a malignancy, and582
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24 had both. Fifteen of the CU patients with
MGUS had a hematologic malignancy compared
with 0.9% of those without MGUS (p<0.001).
Patients presenting with a new diagnosis of CU at
an older age (>56 years) were more likely to have
associated underlying MGUS. The occurrence of
MGUS in this group was higher than its reported
incidence in the general population. There are
also references to the association of CU with
malignancies of the colon, rectum and lung,
Hodgkin disease and non-Hodgkin lymphoma (40),
and hairy-cell leukemia (41).
The case of heart AS in our patient is in
certain respects atypical, because of the previous
concomitant unexplained occurrence of urticaria
and polyarthralgias, which began several months
before the final admission to the hospital with a
clinical picture of superior vena cava syndrome.
A complete study for an etiologic diagnosis to
explain the occurrence of urticaria had been
performed during the previous episodes but was
unsuccessful. Although we cannot establish a
cause and effect relationship between the tumor
and the occurrence of urticaria, defining a
paraneoplastic syndrome, we think such an
association is possible. The proof would be the
resolution of urticaria after treatment of the
tumor, which was not possible due to the patient's
death.
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